Zobrazeno 1 - 10
of 14
pro vyhledávání: '"fuai lu"'
Autor:
Lei Zhang, Xia Zhang, Hong Zhu, Zhanguo Li, Jing He, Yan Du, Xuewu Zhang, Jian Xu, Fei Wang, Jie Wu, Qing Zhao, Shuang Liu, Miao Shao, Miao Miao, Xiaoying Zhang, Xiaoping Zhang, Jin Lin, Zhibin Chen, Shengyun Liu, Xiao Wu, Ru Li, Lianjie Shi, Hongjiang Liu, Yao Chen, Feng Yu, Qingwen Wang, Liyun Zhang, Li Long, Honglian Yu, Yuan An, Huifang Guo, Lingyan Lei, Yanjie Ding, Rui Wu, Yucui Li, Huali Miao, Ruiying Jiao, Lixia Pang, Xueming Yao, Xiaofei Shi, Luping Cui, Fuai Lu, Kangkai Luo, Simeng Zhao, Yongfu Wang, Shulin Song, Xiaoyuan Zhou, Shumei Shi, Ruiyun Yu, Wenqiang Fan
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss 1 (2022)
Objective Infection is a major cause of death in patients with SLE. This study aimed to explore the infection rate in patients with SLE receiving a low dose of intravenous cyclophosphamide (IV-CYC).Methods Clinical parameters of 1022 patients with SL
Externí odkaz:
https://doaj.org/article/f615c3388764433e9ae69f653a8937b1
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Oxidative stress is one of the important factors involved in the pathogenesis of idiopathic pulmonary fibrosis (IPF). The equilibrium of Nuclear factor-erythroid-related factor 2 (Nrf2)/[BTB (broad-complex, tramtrack and bric-a-br
Externí odkaz:
https://doaj.org/article/10cca3474312473ba3e960f9ec72580a
Autor:
Di Wu, Jing Li, Dong Xu, Merrill, Joan T., van Vollenhoven, Ronald F., Yi Liu, Jiankang Hu, Yang Li, Fen Li, Chenghui Huang, Guochun Wang, Xiaomei Li, Jianhong Zhao, Dongbao Zhao, Cibo Huang, Huaxiang Liu, Wei Wei, Guixiu Shi, Fuai Lu, Xiaoxia Zuo
Publikováno v:
Annals of the Rheumatic Diseases; Apr2024, Vol. 83 Issue 4, following p475-487, 22p
Autor:
Ju Liu, Fuai Lu, Niansheng Yang, Lie Dai, Yingxue Cathy Liu, Ning Tie, Lin Liu, Xiumei Liu, Kexia Chai, Xiaowei Gong, H. Sun, Y Wang, Zhenyu Jiang, Lingyun Sun, Guixiu Shi, Xiaomei Li, Jian Wu, Cheng Zhao, Zhanyun Da, Ling Wang, Hua Wei, Zhenchun Zhang, Zhanguo Li, Yanying Liu, Li Luo, Jinying Lin, Linjie Chen, Qian Guo, Lijun Wu, Hui Song, Shengyun Liu
Publikováno v:
Rheumatology and Therapy. 9:175-189
This phase III trial (NCT04178850) evaluated the efficacy, safety, and immunogenicity of GB242, an infliximab biosimilar, vs. infliximab (Remicade®) reference product in patients with moderate-to-severe active rheumatoid arthritis (RA) combination w
Publikováno v:
Annals of translational medicine. 10(22)
Pulmonary fibrosis, which is a frequent manifestation of connective tissue disease (CTD), is a leading cause of morbidity and mortality. However, the role of long non-coding ribonucleic acids (lncRNAs) in CTD-associated pulmonary fibrosis requires cl
Autor:
Miao Shao, Miao Miao, Xia Zhang, Xiaoying Zhang, Yuan An, Huifang Guo, Lingyan Lei, Qing Zhao, Yanjie Ding, Jin Lin, Rui Wu, Feng Yu, Yucui Li, Huali Miao, Liyun Zhang, Yan Du, Ruiying Jiao, Lixia Pang, Li Long, Xueming Yao, Xiaofei Shi, Fei Wang, Luping Cui, Lei Zhang, Shengyun Liu, Fuai Lu, Kangkai Luo, Simeng Zhao, Yongfu Wang, Xiao Wu, Qingwen Wang, Hongjiang Liu, Shulin Song, Xiaoyuan Zhou, Xiaoping Zhang, Shumei Shi, Hong Zhu, Yao Chen, Honglian Yu, Jie Wu, Ruiyun Yu, Wenqiang Fan, Shuang Liu, Jian Xu, Zhibin Chen, Lianjie Shi, Jing He, Xuewu Zhang, Zhanguo Li, Ru Li
Publikováno v:
Lupus Science & Medicine. 9:e000779
ObjectiveInfection is a major cause of death in patients with SLE. This study aimed to explore the infection rate in patients with SLE receiving a low dose of intravenous cyclophosphamide (IV-CYC).MethodsClinical parameters of 1022 patients with SLE
Autor:
Y Wang, Yanying Liu, Zhanyun Da, Ling Wang, Fuai Lu, Hua Wei, Xiaowei Gong, Jian Wu, Zhenyu Jiang, Li Luo, Niansheng Yang, Lie Dai, Shengyun Liu, Yingxue Cathy Liu, Kexia Chai, Linjie Chen, Ju Liu, Lijun Wu, Xiumei Liu, Qian Guo, H. Sun, Guixiu Shi, Zhenchun Zhang, Xiaomei Li, Cheng Zhao, Ning Tie, Lingyun Sun, Jinying Lin, Zhanguo Li, Lin Liu, Hui Song
Background: This double-blind, active-controlled, randomized, multicenter phase III study evaluated the efficacy, safety and immunogenicity of GB242, an infliximab biosimilar, vs infliximab (Remicade®) reference product in patients with moderate to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3863bba85fd20d35223cefa0a955406
https://doi.org/10.21203/rs.3.rs-436813/v1
https://doi.org/10.21203/rs.3.rs-436813/v1
Publikováno v:
Molecular Medicine Reports
Pulmonary fibrosis is an excessive repair response to tissue damage, triggering hyperplasia of fibrotic connective tissues; however, there is no effective treatment in a clinical setting. The purpose of the present study was to investigate the roles
Autor:
Li Luo, Ning Tie, H. Sun, Zhenchun Zhang, Zhenyu Jiang, Guixiu Shi, Lie Dai, Yingxue Cathy Liu, Niansheng Yang, Zhanguo Li, Lin Liu, Cheng Zhao, Hui Song, Shengyun Liu, Ju Liu, Xiaowei Gong, Fuai Lu, Xiumei Liu, Kexia Chai, Jinying Lin, Lijun Wu, Linjie Chen, Y Wang, Zhanyun Da, Ling Wang, Hua Wei, Jian Wu, Qian Guo, Yanying Liu, Lingyun Sun, Xiaomei Li
Publikováno v:
SSRN Electronic Journal.
Objectives: This double-blind, active-controlled, randomized, multicenter phase III study evaluated the efficacy, safety and immunogenicity of GB242 , an infliximab biosimilar, vs infliximab (Remicade®) reference product in patients with moderate to
Objective:The apoptotic signaling pathway is obviously disordered in systemic lupus erythematosus (SLE). Natural IgM (nIgM) is important in clearing apoptotic cells and preventing them from triggering deleterious autoimmunity. B-1- and innate-like
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da97388717dac886c650eff4fac98be3
https://doi.org/10.22541/au.160387924.49172232/v1
https://doi.org/10.22541/au.160387924.49172232/v1